Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-000480

Chief Financial Officer gave up 4,578 shares (to pay taxes)

  • Chief Financial Officer acquired 11,188 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tsuchimoto Kim R · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-31 Exercise or conversion : show line 1 in the form +9,957 47,943 D
2023-12-31 Shares withheld for taxes : show line 2 in the form −4,073 $0.34 $1,386 43,870 D
2024-01-01 Exercise or conversion : show line 3 in the form +1,231 45,101 D
2024-01-01 Shares withheld for taxes : show line 4 in the form −505 $0.34 $172 44,596 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-31 Exercise or conversion : show line 5 in the form Restricted Stock Units −9,957 95,556 D
2024-01-01 Exercise or conversion : show line 6 in the form Restricted Stock Units −1,231 94,325 D
Loading xslF345X05/rdgdoc.xml…